Phoenix, AZ, United States of America

Karen Kibler

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Tempe, AZ (US) (2017)
  • Phoenix, AZ (US) (2019 - 2022)
  • Scottsdale, AZ (US) (2020 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karen Kibler

Introduction

Karen Kibler is a prominent inventor based in Phoenix, Arizona, known for her significant contributions to the field of immunology. With a total of six patents to her name, she has made remarkable strides in developing innovative solutions for vaccination and immune response.

Latest Patents

Among her latest patents, Kibler has developed modified immunization vectors, which relate to recombinant vectors and methods for their use. These vectors are designed to be immunogenic, enhancing the effectiveness of vaccinations. Additionally, she has created HIV vaccination compositions that comprise vaccinia virus-like particles (VLPs) and plant-produced VLPs presenting HIV antigens. These compositions aim to generate a robust immune response against the human immunodeficiency virus (HIV) and outline methods for their application.

Career Highlights

Throughout her career, Karen Kibler has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas and Arizona State University. Her work in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Kibler has collaborated with notable colleagues, including Bertram L. Jacobs and Giuseppe Pantaleo, further enhancing her research and innovation in the field.

Conclusion

Karen Kibler's innovative work in immunology and her dedication to advancing vaccination technologies have made her a key figure in her field. Her contributions continue to impact the development of effective immunization strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…